v3.25.1
SCHEDULE OF BREAKDOWN OF SIGNIFICANT OPERATING EXPENSES (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Dec. 31, 2024
Revenue $ 47  
Cost of revenues 61  
Gross loss (14)  
Research and development by significant expense:      
Research and development 1,309 1,458  
General and administrative by significant expense:      
General and administrative 1,421 4,315  
Total operating expenses 2,730 5,773  
Loss from operations (2,730) (5,787)  
Forward sales contract expense (5,335)  
Change in fair value of warrant liabilities 1 (70)  
Interest income (expense), net 5 (786)  
Other expense, net (135)  
Total other expense, net (5,464) (856)  
Loss before income taxes (8,194) (6,643)  
Provision for income taxes (8) (4)  
Net loss (8,202) (6,647)  
Cash 1,918   $ 1,729
MSA/License Fees [Member]      
Research and development by significant expense:      
Research and development 637 812  
Study Fees [Member]      
Research and development by significant expense:      
Research and development 352 64  
Professional Fees [Member]      
Research and development by significant expense:      
Research and development 156 103  
General and administrative by significant expense:      
General and administrative 386 1,285  
Payroll and Related [Member]      
Research and development by significant expense:      
Research and development 96 325  
General and administrative by significant expense:      
General and administrative 394 532  
Other [Member]      
Research and development by significant expense:      
Research and development [1] 68 154  
General and administrative by significant expense:      
General and administrative [2] 148 360  
Stock Based Compensation [Member]      
General and administrative by significant expense:      
General and administrative 486 237  
Occupancy Expense [Member]      
General and administrative by significant expense:      
General and administrative $ 7 $ 1,901  
[1] Other includes certain lab supply expenses, amounts related to the close out of a former clinical trial, allocated occupancy costs, stock-based compensation, and depreciation.
[2] Other includes expenses related to insurance, information technology, travel, banking, depreciation and other miscellaneous expenses.